Provided by Tiger Trade Technology Pte. Ltd.

Repligen

167.22
-7.6400-4.37%
Post-market: 167.22-0.00250.00%19:34 EDT
Volume:2.63M
Turnover:442.14M
Market Cap:10.62B
PE:229.07
High:175.04
Open:174.75
Low:165.99
Close:174.86
52wk High:198.87
52wk Low:100.99
Shares:63.49M
Float Shares:60.53M
Volume Ratio:1.76
T/O Rate:4.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:5.03
PE(LYR):194.44

Loading ...

Q/C Technologies Director Chelsea Voss Resigns from Board

Reuters
·
Sep 12

BioLife Solutions Nears Completion of Repligen Acquisition

TIPRANKS
·
Sep 10

BioLife Solutions Announces Special Shareholder Meeting on Merger Agreement

Reuters
·
Sep 10

Repligen Outlines Strategy to Drive Mid-Teens Revenue CAGR Through 2030, Targets ~30% Adjusted Ebitda Margin

Reuters
·
Sep 10

UBS Adjusts Price Target on Repligen to $225 From $195, Keeps Buy Rating

MT Newswires Live
·
Sep 09

Repligen clears antitrust hurdle in BioLife Solutions acquisition

TIPRANKS
·
Sep 09

Repligen Says HSR Waiting Period Expires for BioLife Solutions Deal

Reuters
·
Sep 09

Repligen CEO Olivier Loeillot Disposes of USD 985,896.05 in Common Shares

Reuters
·
Sep 09

BioLife Solutions Sets October Vote on Cash‑and‑Stock Merger With Repligen

TIPRANKS
·
Sep 05

Repligen (RGEN) Dropped, So What Is Behind The Latest Attention?

Simply Wall St.
·
Aug 29

Will Stronger 2026 Guidance and Broad-Based Growth Change Repligen's (RGEN) Narrative

Simply Wall St.
·
Aug 28

Repligen CEO, CFO to Join Wells Fargo Healthcare Conference Analyst Discussion

Reuters
·
Aug 26

Repligen CEO Olivier Loeillot Disposes of 5,426 Common Shares Worth $976,680

Reuters
·
Aug 22

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Repligen (RGEN)

TIPRANKS
·
Aug 21

Q/C Technologies CFO Todd Fagan Files Initial Beneficial Ownership Statement

Reuters
·
Aug 18

Q/C Technologies Q2 Net Loss Widens to $6.62 Million; Operating Loss Widens to $6.79 Million

Reuters
·
Aug 13

BioLife Solutions Swings to Q2 FY26 GAAP Net Income of $45.1 Million; Revenue Rises 21% to $28.5 Million vs Q2 FY25

Reuters
·
Aug 07

Q/C Technologies Names Yossef Ehrlichman Founding Manager of Photonic Integrated Circuit Development

Reuters
·
Aug 04

BioLife Details Strategic Repligen Merger Communication to Staff

TIPRANKS
·
Aug 04

Repligen Says BioLife Deal Targets Q4 Close Pending Regulatory, Shareholder Approvals

Reuters
·
Aug 04